Hepion Pharmaceuticals, Inc. (HEPA) Financials
HEPA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 25.0 million | 8.8 million |
| 2023-06-30 | 36.5 million | 10.1 million |
| 2023-03-31 | 60.2 million | 10.4 million |
| 2022-12-31 | 60.2 million | 10.4 million |
HEPA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -11.2 million | 318911 |
| 2023-06-30 | -12.5 million | -1.1 million |
| 2023-03-31 | -4.8 million | 231943 |
| 2022-12-31 | -4.8 million | 231943 |
HEPA Net Income
No data available :(
HEPA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 19.3 million | - | 241543 |
| 2023-06-30 | 30.5 million | - | - |
| 2023-03-31 | 51.2 million | - | - |
| 2022-12-31 | - | - | 53614 |
HEPA Shares Outstanding
HEPA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 2582 | 8.5 million | 2.1 million | - |
| 2023-06-30 | 16538 | 11.9 million | 2.3 million | - |
| 2023-03-31 | 16336 | 7.5 million | 385761 | - |
| 2022-12-31 | 16336 | 7.5 million | 385761 | - |
HEPA Cost of Revenue
No data available :(
HEPA
Price: $1.37
52 week price:
Earnings Per Share: -12.42 USD
P/E Ratio: -0.15
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 70741
Market Capitalization: 11.1 million